Ignite Creation Date:
2024-05-06 @ 12:13 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01527734
Status:
COMPLETED
Last Update Posted:
2012-02-08
First Post:
2012-01-23
Brief Title:
Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin TTX in Healthy Volunteers
Sponsor:
Wex Pharmaceuticals Inc
Organization:
Wex Pharmaceuticals Inc
Study Overview
Official Title:
COMPARISON OF THE PHARMACOKINETICS AND SAFETY OF LIQUID 30 µg AND LYOPHILIZED TETRODOTOXIN 15 µg AND 30 µg FOLLOWING SINGLE AND TWICE DAILY SUBCUTANEOUS DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS-DETERMINATIONS IN BLOOD AND URINE
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study design is a randomized double-blind placebo-controlled parallel-group dose comparison with a open-label crossover formulation comparison
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None